Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-17-000264
Filing Date
2017-03-03
Accepted
2017-03-03 18:48:11
Documents
2
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4770
2 POWER OF ATTORNEY FOR DR. KNEELAND YOUNGBLOOD youngbloodpoa_march2017.htm EX-24 6484
  Complete submission text file 0000950138-17-000264.txt   12634
Mailing Address C/O GAP, INC. 2 FOLSOM ST. SAN FRANCISCO CA 94105
Business Address
YOUNGBLOOD DR KNEELAND (Reporting) CIK: 0001137820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 17665983

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations